Order results by:
| Issue | Title | |
| Vol 3, No 2 (2007) | CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS | Abstract similar documents |
| D. V. Nebieridze | ||
| "... and ability to improve endothelium function of non-dihydropyridine calcium antagonist, diltiazem (Altiazem RR ..." | ||
| Vol 4, No 2 (2008) | FROM THE SHORT ACTING NIFEDIPINE TO AMLODIPINE AND FIXED COMBINATIONS. HIGHLIGHTS THE PROBLEM FROM THE CURRENT GUIDELINES POINT OF VIEW | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva | ||
| "... Calcium antagonists (CA) therapy of patients with arterial hypertension is focused on the base ..." | ||
| Vol 2, No 4 (2006) | CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY | Abstract similar documents |
| R. I. Striuk | ||
| "... should be used immediately. Dihydropyridine calcium antagonists (CA) is drugs of choice for HT treatment ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS | Abstract similar documents |
| Y. A. Karpov, V. V. Buza | ||
| "... . Advantages of dihydropyridine calcium antagonists (DPCA) for AH treatment in elderly patients are proved ..." | ||
| Vol 9, No 1 (2013) | LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov | ||
| "... Classification, modes of action and clinical effects of calcium channel blockers are presented ..." | ||
| Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract similar documents |
| S. V. Nedogoda | ||
| "... Results of randomized clinical trials on the usage of calcium antagonists (CA) in order to prevent ..." | ||
| Vol 7, No 3 (2011) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS. POSITION OF NIFEDIPINE IN MODERN CARDIOLOGY PRACTICE | Abstract similar documents |
| A. A. Garganeeva | ||
| Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| E. V. Shilova, S. Y. Martsevich | ||
| "... Classification of calcium antagonists (CA) is presented. Results of the large clinical trials ..." | ||
| Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract similar documents |
| T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
| Vol 6, No 1 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION | Abstract similar documents |
| S. A. Boitsov, R. M. Linchak | ||
| "... attention is paid to usage of ACE inhibitor and calcium antagonist combination. ..." | ||
| Vol 6, No 3 (2010) | EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| D. A. Yakhontov, N. F. Balabanova | ||
| "... of the second group received any other antihypertensive therapy except dihydropyridine calcium antagonists ..." | ||
| Vol 10, No 4 (2014) | TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE | Abstract similar documents |
| O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov | ||
| Vol 11, No 5 (2015) | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation | Abstract similar documents |
| E. I. Emelina, G. E. Gendlin | ||
| "... Features and possibility of application of the calcium channel blocker lercanidipine in cardiology ..." | ||
| Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The classification of calcium antagonists is presented. There were considered the results of large ..." | ||
| Vol 6, No 5 (2010) | NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION | Abstract similar documents |
| O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya | ||
| "... are presented. The advantages of ACE inhibitor+calcium channel blocker combination are shown in terms ..." | ||
| Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchenov | ||
| "... converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Data on the efficacy ..." | ||
| Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... disease are presented. Special attention is paid to the fixed combination of calcium antagonist ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| "... , calcium antagonists, mainly amlodipine, have the greatest potential for the variability reduction ..." | ||
| Vol 6, No 1 (2010) | AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... Author discusses antiatherosclerotic effects of dihydropyridine calcium channel blocker ..." | ||
| Vol 13, No 3 (2017) | HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
| O. A. Kislyak, A. V. Starodubova, A. A. Kopelev | ||
| "... of using the last generation of calcium channel blockers in this clinical situation with an emphasis ..." | ||
| Vol 7, No 3 (2011) | TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR | Abstract similar documents |
| I. M. Sokolov | ||
| "... medications that slow down HR: beta blockers (BB), If-channel inhibitors, nondihydropyridine calcium channel ..." | ||
| Vol 6, No 4 (2010) | POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... and safety of the modern calcium channel blocker (CCB), lercanidipine, are presented. Results of these trials ..." | ||
| Vol 9, No 1 (2013) | THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE | Abstract similar documents |
| M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova | ||
| Vol 3, No 5 (2007) | CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich | ||
| Vol 9, No 3 (2013) | THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS | Abstract similar documents |
| M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β ..." | ||
| Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
| S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
| "... Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan ..." | ||
| Vol 7, No 4 (2011) | COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) | Abstract similar documents |
| O. V. Dralova, M. L. Maksimov | ||
| Vol 11, No 2 (2015) | A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE | Abstract similar documents |
| B. B. Gegenava, O. M. Drapkina | ||
| "... of the selective antagonist of mineralocorticoid receptor eplerenone are analyzed. The advantages of eplerenone ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure ..." | ||
| Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya | ||
| Vol 19, No 4 (2023) | Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy | Abstract similar documents |
| S. R. Gilyarevsky, D. O. Ladygina | ||
| "... , despite the normal blood pressure level. Modern data on the role of mineralocorticoid receptor antagonists ..." | ||
| Vol 2, No 1 (2006) | ARE ALL THE PROLONGED DRUG FORMULATIONS OF NIFEDIPINE THE SAME? | Abstract similar documents |
| V. G. Kukes, D. A. Sychev | ||
| "... Publication is devoted to the calcium antagonist nifedipine in drug formulations of the prolonged ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... + diet), group A2 (ACE inhibitor + fluvastatin), group B1 (angiotensin II receptor antagonist (ARA II ..." | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| "... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..." | ||
| Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... and angiotensin II receptor antagonists (ARA) in patients with COVID-19 is analyzed in the article ..." | ||
| Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya | ||
| "... receptor antagonist (ARA), valsartan at the cardiovascular continuum (CVC) stages. Material and methods ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| "... clinical trials. The triple combination of calcium antagonist, angiotensin II receptor blocker and thiazide ..." | ||
| Vol 9, No 2 (2013) | PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET | Abstract similar documents |
| L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova | ||
| "... levels of albumin, total calcium, phosphorus, total cholesterol (TC), low (LDL) and high density ..." | ||
| Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
| M. A. Ninci, R. Magliocca, A. Malliani | ||
| "... Цель. Оценить эффективность лерканидипина (антагониста кальция из группы дигидропиридинов) у ..." | ||
| Vol 13, No 4 (2017) | PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY | Abstract similar documents |
| O. M. Drapkina, D. U. Akasheva | ||
| "... with reduced ejection fraction (<40%). Antagonists of mineralocorticoid receptors, along with angiotensin ..." | ||
| Vol 5, No 3 (2009) | FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY | Abstract similar documents |
| O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova | ||
| Vol 3, No 2 (2007) | CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS | Abstract similar documents |
| V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina | ||
| "... antagonists (ARA II) – candesartan (Atacand) and losartan (Cosaar) in patients with chronic cor pulmonale (CCP ..." | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... Amlodipine combines the most important clinical effects of calcium antagonists with minimal side ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| Vol 14, No 4 (2018) | Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases | Abstract similar documents |
| O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin | ||
| "... with atrial fibrillation (AF) are of leading importance. Recently, non-vitamin K antagonist oral ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| N. M. Nikitina, A. P. Rebrov | ||
| "... into account wide usage of non steroid antiinflammatory drugs calcium antagonists or angiotensin II receptor ..." | ||
| Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
| A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
| "... for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from ..." | ||
| Vol 12, No 1 (2016) | Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) | Abstract PDF (Eng) similar documents |
| E. L. Trisvetova, S. V. Gubkin | ||
| "... , specific therapy with calcium channel blockers, prostacyclin analogues, endothelin receptor antagonists ..." | ||
| Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
| A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
| "... to clinical guidelines vitamin K antagonists (VKAs) should be used as treatment of choice for thrombus ..." | ||
| Vol 20, No 4 (2024) | Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension | Abstract similar documents |
| O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova | ||
| "... receptor antagonist spironolactone. However, the inclusion of this drug in antihypertensive therapy ..." | ||
| Vol 17, No 3 (2021) | Ability of Evaluation Coronary Calcium Index Based on Ultra-Low-Dose Computed Tomography Used in Moscow Lung Cancer Screening Project | Abstract similar documents |
| A. E. Nikolaev, A. N. Shapiev, O. A. Korkunova, G. Z. Mukhutdinova, P. V. Tkacheva, M. M. Suleymanova, A. N. Shapieva, D. M. Ramazanova, M. N. Rzayev, V. A. Gombolevsky | ||
| "... Aim. Determination of the possibility of reliable quantitative assessment of the coronary calcium ..." | ||
| Vol 2, No 2 (2006) | PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING | Abstract similar documents |
| N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich | ||
| "... %, beta-blockers – 28%, diuretics – 26% and calcium antagonists – 10%. Other classes of antihypertensive ..." | ||
| Vol 15, No 4 (2019) | According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention | Abstract similar documents |
| Company Pfizer | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... -blockers, ACEI, ARB, diuretics, while calcium antagonists did not reduce the frequency of headaches ..." | ||
| Vol 5, No 4 (2009) | CLINICO-ECONOMICAL ANALYSIS OF THE TREATMENT EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES | Abstract similar documents |
| L. A. Haisheva, S. V. Shlyk, T. Y. Bykovskaya | ||
| "... calcium antagonists if it is needed in patients with HT of 2 degree. ..." | ||
| Vol 16, No 4 (2020) | Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist | Abstract similar documents |
| M. V. Zhuravleva, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova, S. A. Belkov, A. I. Dmitriev, G. I. Gorodetskaya | ||
| "... or angiotensin II receptor blocker) with a calcium antagonist or diuretic. The combination of lisinopril ..." | ||
| Vol 3, No 2 (2007) | RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION | Abstract similar documents |
| M. M. Batyushin, I. V. Derevyankina, M. Z. Gasanov, O. V. Akopova, K. I. Babiyan, Y. N. Boychenko, N. V. Vasilchenko, T. A. Gabysyan, S. Ch. Gayboryan, I. S. Golovatenko, N. M. Demkova, D. O. Dmitriev, E. V. Kirtava, O. L. Kotyankova, G. V. Ludanova, S. A. Lyashenko, A. E. Malichina, O. I. Poroshenko, A. V. Svechnikova, I. Y. Sidorov, E. V. Solyannikova, I. D. Tascheyan, E. A. Heygetyan, S. E. Evruyan | ||
| "... converting enzyme (ACE) inhibitor, thiazid diuretic (indapamide) and dihydropyridine calcium antagonist ..." | ||
| Vol 3, No 4 (2007) | EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova | ||
| "... Aim. To assess an efficacy of antihypertensive therapy with calcium antagonist, angiotensin ..." | ||
| Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
| M. V. Leonova | ||
| "... . The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium ..." | ||
| Vol 11, No 2 (2015) | ALCOHOL-INDUCED CARDIAC RHYTHM DISORDERS IN PATIENTS WITH ALCOHOL DEPENDENCE: TYPES OF ARRHYTHMIAS, MECHANISMS OF ORIGIN, PARTICULARITIES OF COURSE AND ANTIARRHYTHMIC THERAPY | Abstract similar documents |
| A. S. Aksel'rod, A. L. Syrkin | ||
| "... and ventricular rhythm disorders. The combination of beta-blocker + dihydropyridine calcium antagonists ..." | ||
| Vol 16, No 5 (2020) | Untapped Possibilities of Antiischemic Therapy after Acute Myocardial Infarction: Data from the PROFILE-IM Register | Abstract similar documents |
| E. P. Kalaydzhyan, S. Yu. Martsevich, N. P. Kutishenko, D. P. Sichinava, O. M. Drapkina | ||
| "... received calcium antagonists (28.9%) or long-acting nitrates (34,2%). During the first year after AMI ..." | ||
| Vol 15, No 5 (2019) | Modern Principles of Treatment of Uncontrolled Hypertension | Abstract similar documents |
| V. I. Podzolkov, A. I Tarzimanova, Z. O. Georgadze | ||
| "... – angiotensin-converting enzyme inhibitors or receptor blockers to angiotensin with a calcium antagonist ..." | ||
| Vol 17, No 2 (2021) | Treatment of Resistant Hypertension in Real Clinical Settings | Abstract similar documents |
| A. S. Maltseva, A. E. Tsygankova, M. A. Gabitova, A. V. Rodionov, V. V. Fomin | ||
| "... ] blocker + calcium-channel blocker [CCB] + diuretic) plus one of the group of reserve drugs ..." | ||
| Vol 6, No 4 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE | Abstract similar documents |
| O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova | ||
| "... (indapamide) and dihydropyridine calcium channel blocker (amlodipine) on ambulatory blood pressure (BP ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... lower than ACE inhibitors. Bisoprolol was most common beta-blocker. Calcium antagonists: if amlodipine ..." | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 15, No 4 (2019) | Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study) | Abstract PDF (Eng) similar documents |
| Yu. A. Balanova, S. A. Shalnova, A. E. Imaeva, А. V. Kapustina, G. A. Muromtseva, S. V. Evstifeeva, V. I. Tarasov, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, S. S. Yakushin, S. A. Boytsov, O. M. Drapkina | ||
| "... .5%, diuretics – 22.7%, calcium antagonists – 15.7%, centrally acting drugs – 3.3%, others – 0.2%. The lack ..." | ||
| Vol 6, No 2 (2010) | RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... and dihydropyridine calcium channel blocker (DCCB), on frequency of cardiovascular events is studied in many trails ..." | ||
| Vol 11, No 3 (2015) | THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... pathogenic mechanisms of hypertension. The combination of an ACE inhibitor and a dihydropyridine calcium ..." | ||
| Vol 13, No 5 (2017) | ACUTE CORONARY SYNDROME DUE TO CORONARY VASOSPASM – CASE REPORT | Abstract similar documents |
| S. D. Klimovskiy, G. G. Gazaryan, M. D. Krichman, P. B. Pisetskiy, A. G. Koledinskiy, T. Sh. Mirilashvili | ||
| "... important practical significance, due to the prevailing benefit of calcium antagonists in the treatment ..." | ||
| Vol 7, No 3 (2011) | COGNITIVE-MNESTIC FUNCTIONS IN ABLE-BODIED AGED PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION IN AMLODIPINE TREATMENT | Abstract similar documents |
| N. N. Ilov, R. N. Shvarts, T. N. Panova | ||
| "... . Monotherapy with calcium channels antagonist, amlodipine, improves CMF in patients with EAH. Amlodipine has ..." | ||
| Vol 7, No 2 (2011) | CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE | Abstract similar documents |
| M. V. Leonova | ||
| "... Contemporary scientific data about mode of action of calcium channel blocker — amlodipine, its ..." | ||
| Vol 17, No 1 (2021) | Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic | Abstract PDF (Eng) similar documents |
| S. Y. Martsevich, Y. V. Lukina, E. D. Zharkova, N. P. Kutishenko | ||
| "... -aldosterone system inhibitors and dihydropyridine calcium antagonists remained unchanged. Conclusion ..." | ||
| Vol 17, No 3 (2021) | Causes, Predisposing Factors and Prevention Directions of Drug-induced Bradycardia (Based on the Results of the Hospital Register of Oardiac Medications Overdoses STORM) | Abstract similar documents |
| N. N. Nikulina, S. V. Seleznev, M. B. Chernysheva, S. S. Yаkushin | ||
| "... - moxonidine (12.3%, its frequency has increased 8.9 times in 5 years, p=0.004), non-dihydropyridine calcium ..." | ||
| Vol 4, No 5 (2008) | AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov | ||
| "... Aim. To study effects of calcium channel blocker, amlodipine on indices of ambulatory blood ..." | ||
| Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... inhibitor and antagonist of angiotensin II receptor are discussed. ..." | ||
| Vol 15, No 5 (2019) | Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis | Abstract similar documents |
| D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... in 70 (59.3%) patients, beta-blockers – in 35 (29.7%), calcium antagonists – in 20 (16.9%), diuretics ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... ,4%) patients received ACE inhibitors, 435 (55%) patients - beta-blockers, 230 (29,1%) patients - calcium ..." | ||
| Vol 16, No 2 (2020) | Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG | Abstract similar documents |
| O. V. Fedorishina, K. V. Protasov, A. M. Torunova | ||
| "... of calcium antagonist and angiotensin converting enzyme (ACE) inhibitor. Material and methods. Hypertensive ..." | ||
| Vol 4, No 5 (2008) | EFFECT OF AMLODIPINE AND OF NIFEDIPINE RETARD ON AUTONOMIC REGULATION OF HEART RATE IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| E. D. Golovanova, T. V. Osipova | ||
| "... Aim. To study the effect of the monotherapy with calcium channel blockers (amlodipine, 5 mg/d ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... blocker [ARB]) and a calcium channel blocker (CCB) or a thiazide / thiazide-like diuretic. The task ..." | ||
| Vol 4, No 4 (2008) | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| S. A. Boytsov, I. P. Kolos | ||
| "... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..." | ||
| Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
| S. G. Kanorskii | ||
| "... of anticoagulant therapy include vitamin K antagonists, such as warfarin, whose benefits are long established ..." | ||
| Vol 16, No 3 (2020) | The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril | Abstract similar documents |
| A. I. Kochetkov, S. V. Batyukina, O. D. Ostroumova, M. Yu. Nazranova, V. N. Butorov | ||
| "... of an angiotensin converting enzyme inhibitor and a calcium channel blocker. The reference drugs in both classes due ..." | ||
| Vol 14, No 3 (2018) | TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk | ||
| "... and amlodipine, as the reference drug of angiotensin II receptor blockers and calcium channel blockers ..." | ||
| Vol 12, No 1 (2016) | The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev | ||
| "... (RR=1.6), atrial fibrillation (RR=1.4). Patients who were treated with calcium channel blockers before ..." | ||
| Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
| "... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..." | ||
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... pressure (BP) levels remains inadequate. Dihydropyridine calcium channel blockers show antihypertensive ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... : selective thromboxane inhibitors, antagonists of thromboxane receptors, blockers of platelet receptors ..." | ||
| Vol 15, No 6 (2019) | Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... single-pill combinations is the combination of an angiotensin II receptor blocker and a calcium channel ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
| S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
| "... and diuretics as monotherapy shared 4th and 5th places in this rating. Calcium channel blockers popularity among ..." | ||
| Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) similar documents |
| M. Tamirci, R. Demirdamar | ||
| "... .1%), angiotensin receptor blockers (ARBs) (22.1%), calcium channel blockers (20.4%), angiotensin converting enzyme ..." | ||
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... Ингибиторы ангиотензинпревращающего фермента (иАПФ) и антагонисты рецепторов к ангиотензину (АРА ..." | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... АПФ (ИАПФ) и антагонистов рецепторов ангиотензина (АРА) на исходы сердечно-сосудистых заболеваний ..." | ||
| Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
| V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
| "... of the combination of thiazide-like diuretic with calcium channel blocker in the morning and ACE inhibitor in bedtime ..." | ||
| Vol 17, No 1 (2021) | Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease | Abstract similar documents |
| O. A. Fomina, S. S. Yakushin | ||
| "... frequent prescription of dihydropyridine calcium channel blocking agents was registered (23.3% vs 2.9% р<0 ..." | ||
| Vol 15, No 2 (2019) | Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice | Abstract similar documents |
| E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova | ||
| "... containing ACE inhibitor (perindopril), calcium channel blocker (amlodipine) and thiazide-like diuretic ..." | ||
| Vol 14, No 4 (2018) | New Clinical Aspects of Eplerenone Use in Clinical Practice | Abstract similar documents |
| S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina | ||
| "... of mineralocorticoid receptor antagonists in patients with heart failure with reduced left ventricular ejection ..." | ||
| 1 - 100 of 185 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
